サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1402482

欧州の脳深部刺激療法市場の2030年予測-地域別分析-製品、用途、エンドユーザー別

Europe Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User

出版日
ページ情報
英文 95 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
欧州の脳深部刺激療法市場の2030年予測-地域別分析-製品、用途、エンドユーザー別
出版日: 2023年10月26日
発行: The Insight Partners
ページ情報: 英文 95 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の脳深部刺激療法市場は、2022年の1億6,914万米ドルから2030年には3億1,988万米ドルに成長すると予測されています。2022年から2030年までのCAGRは8.3%で成長すると推定されています。

低侵襲手術の需要増加が欧州の脳深部刺激療法市場を牽引

脳深部刺激療法は、ジストニア、パーキンソン病、本態性振戦などの運動障害の治療に用いられる低侵襲標的手術です。低侵襲手術（MIS）には、従来の手術法に比べていくつかの利点があります。MISは身体への外傷を最小限に抑え、術後の痛みを軽減し、回復速度を速め、治療成績を向上させる。ロボット手術は低侵襲手術における最新の進化であり、従来の腹腔鏡手術で使用されていたのと同じ小さな切開創を使用する精密機器を外科医に提供します。MISは開腹手術に比べて出血量が少なく、鎮痛剤の使用量も少なく、術後の入院期間も短いです。さらに、低侵襲手術は従来の手術法よりも高い正確率を示しています。また、これらの手術では、細い管やカメラを挿入するのに十分な大きさの小さな切開が必要です。MISのこうした利点は入院患者を増やし、高い手術罹患率や死亡率に直面する高齢患者に手術を求めるよう促しています。このように、低侵襲手術の利点による需要の高まりが、欧州の脳深部刺激療法（DBS）市場の成長を後押ししています。

欧州の脳深部刺激療法市場概要

医療分野では、神経外科手術には高度な機器と高度な資格を持つ医療専門家が必要です。ドイツの神経外科医は高度な資格を持つ専門家であり、最新のプロトコールや手術手順に従っています。ドイツの神経学センターには、国際的な品質基準を満たす最新の診断機器と低侵襲手術機器が設置されています。Charite-Universitatsmedizin Berlinで発表された「Deep brain stimulation in Parkinson's」では、パーキンソン病は、アルツハイマー病に次いで2番目に多い神経変性疾患となっています。ドイツでは2022年12月に約40万人が罹患しており、人口動態の高齢化によりその数は増加しています。若年層を含め、神経変性疾患を患う人が増えており、ドイツでは200万人以上が認知症やパーキンソン病を患っています。ドイツアルツハイマー病患者協会によると、2020年には9,450人がアルツハイマー病で死亡し、最多を記録します。アルツハイマーの診断による入院と死亡の増加は、ドイツの高齢化に大きく依存しています。65歳以上の人口は2020年の間に33％増加し、1,830万人に達しました。したがって、高齢化は神経障害の増加をもたらし、これが今後数年間の市場成長を押し上げると予想されます。

欧州の脳深部刺激療法市場の収益と2030年までの予測（金額）

欧州の脳深部刺激療法市場のセグメンテーション

欧州の脳深部刺激療法市場は、製品、用途、エンドユーザー、国に区分されます。

製品別では、欧州の脳深部刺激療法市場は、シングルチャネル脳深部刺激療法装置、デュアルチャネル脳深部刺激療法装置、ソフトウェアとアクセサリに区分されます。2022年には、デュアルチャネル深部脳刺激装置セグメントが欧州脳深部刺激療法市場で最大のシェアを記録しました。

用途別では、欧州の脳深部刺激療法市場は、パーキンソン病、振戦、ジストニア、てんかん、アルツハイマー病、その他に区分されます。2022年、パーキンソン病セグメントは欧州の脳深部刺激療法市場で最大のシェアを記録しました。

エンドユーザー別に見ると、欧州の脳深部刺激療法市場は病院、神経科クリニック、外来手術センター、その他に区分されます。2022年には、病院セグメントが欧州脳深部刺激療法市場で最大のシェアを記録しました。

国別では、欧州の脳深部刺激療法市場は、ドイツ、英国、フランス、イタリア、スペイン、その他の欧州に区分されます。2022年には、ドイツセグメントが欧州の脳深部刺激療法市場で最大のシェアを記録しました。

Abbott Laboratories、Aleva Neurotherapeutics SA、Boston Scientific Corp社、Medtronic Plc、Newronika SpAは、欧州の脳深部刺激療法市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察
  • 欧州の脳深部刺激療法市場：国別

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の脳深部刺激療法市場情勢

  • イントロダクション
  • 欧州PEST分析
  • 比較分析
    • 脳深部刺激療法と病変形成手技の比較
    • 神経疾患における病変形成手順
    • 2022年に実施される欧州の脳深部刺激療法の国別実施件数

第5章 欧州の脳深部刺激療法市場：主要産業力学

  • 主要市場の促進要因
    • 神経疾患の有病率の上昇
    • 低侵襲手術に対する需要の増加
  • 市場抑制要因
    • 脳深部刺激療法に伴う副作用
  • 市場機会
    • 脳深部刺激療法における技術の進歩と承認
  • 今後の動向
    • 研究開発の活発化
  • 影響分析

第6章 脳深部刺激療法市場：欧州市場分析

  • 欧州の脳深部刺激療法市場売上高、2022～2030年

第7章 欧州の脳深部刺激療法市場：製品別収益と2030年までの予測

  • イントロダクション
  • 欧州の脳深部刺激療法市場：製品別収益シェア（2022年・2030年）
  • シングルチャネル脳深部刺激療法装置
  • デュアルチャネル脳深部刺激療法装置
  • ソフトウェアとアクセサリー

第8章 欧州の脳深部刺激療法市場：用途別収益と2030年までの予測

  • イントロダクション
  • 欧州の脳深部刺激療法市場：用途別収益シェア（2022年・2030年）
  • パーキンソン病
  • 振戦
  • アルツハイマー病
  • ジストニア
  • てんかん
  • その他

第9章 欧州の脳深部刺激療法市場：エンドユーザー別収益と2030年までの予測

  • イントロダクション
  • 欧州の脳深部刺激療法市場：エンドユーザー別収益シェア（2022年・2030年）
  • 病院
  • 神経クリニック
  • 外来手術センター
  • その他

第10章 欧州の脳深部刺激療法市場：国別分析

  • 概要
    • 欧州の脳深部刺激療法市場：国別
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州

第11章 COVID-19前後の影響

  • COVID-19前後の影響

第12章 欧州の脳深部刺激療法市場業界情勢

  • イントロダクション
  • 脳深部刺激療法市場の成長戦略
  • 有機的成長戦略
  • 概要
  • 無機的成長戦略
  • 概要

第13章 欧州の脳深部刺激療法市場：主要企業プロファイル

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Medtronic Plc
  • Boston Scientific Corp
  • Newronika SpA

第14章 付録

図表

List Of Tables

  • Table 1. Europe Deep Brain Simulation Market Segmentation
  • Table 2. Comparison of Deep Brain Stimulation and Lesioning Procedures
  • Table 3. Europe Deep Brain Stimulation Surgical Procedures Performed in 2022, by Country.
  • Table 4. Germany Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 5. Germany Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 6. Germany Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 7. UK Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 8. UK Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 9. UK Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 10. France Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 11. France Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 12. France Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 13. Italy Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 14. Italy Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 15. Italy Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 16. Spain Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 17. Spain Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 18. Spain Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 19. Rest of Europe Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 20. Rest of Europe Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 21. Rest of Europe Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 22. Recent Organic Growth Strategies in Deep Brain Stimulation Market
  • Table 23. Recent Inorganic Growth Strategies in the Europe deep brain simulation market
  • Table 24. Glossary of Terms, Europe Deep Brain Simulation Market

List Of Figures

  • Figure 1. Europe Deep Brain Simulation Market Segmentation, By Geography
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Europe Deep Brain Simulation Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Single Channel Deep Brain Stimulator: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Dual Channel Deep Brain Stimulator: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Software and Accessories: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Europe Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 11. Parkinson's Disease: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Tremor: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Alzheimer's Disease: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Dystonia: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Epilepsy: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Europe Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 18. Hospitals: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Neurology Clinics: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Ambulatory Surgical Centers: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe Deep Brain Simulation Market, By Country, 2022 ($Mn)
  • Figure 23. Europe Deep Brain Simulation Market, By Key Countries, 2022 And 2030 (%)
  • Figure 24. Germany Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 25. UK Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 26. France Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 27. Italy Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 28. Spain Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Europe Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 30. Pre & Post Covid-19 Impact
  • Figure 31. Growth Strategies in Deep Brain Stimulation Market
目次
Product Code: BMIRE00029019

The Europe deep brain simulation market is expected to grow from US$ 169.14 million in 2022 to US$ 319.88 million by 2030. It is estimated to grow at a CAGR of 8.3% from 2022 to 2030.

Increasing Demand for Minimally Invasive Surgery Drive Europe Deep Brain Simulation Market

Deep brain stimulation is a minimally invasive targeted surgery used to treat movement disorders in dystonia, Parkinson's disease, and essential tremor. Minimally invasive surgeries (MIS) offer several advantages over traditional surgical techniques. MIS minimizes trauma to the body, reduces postoperative pain, increases recovery speed, and improves outcomes. Robotic procedures represent the latest evolution in minimally invasive procedures, providing surgeons with precision equipment that uses the same small incisions used in traditional laparoscopy. MIS leads to less blood loss, less analgesic use, and shorter postoperative hospital stay than open surgery. In addition, minimally invasive surgery indicates a higher accuracy rate than traditional surgical methods. Also, these procedures require tiny incisions large enough to insert thin tubes and cameras. These benefits of MIS are increasing inpatients and have encouraged older patients who face high operative morbidity and mortality to seek surgery. Thus, the rising demand for minimally invasive surgeries due to their advantages bolsters the Europe deep brain stimulation (DBS) market growth.

Europe Deep Brain Simulation Market Overview

In the medical field, neurosurgery requires advanced equipment and highly qualified medical professionals. German neurosurgeons are highly qualified specialists; they follow the latest protocols and surgical procedures. Neurology centers in Germany have the most modern diagnostic and minimally invasive surgical devices that meet international quality standards. According to a study published at Charite-Universitatsmedizin Berlin entitled "Deep brain stimulation in Parkinson's: A new algorithm to adjust stimulation settings has been developed," Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's. Approximately 400,000 people were affected with the disease in Germany in December 2022, and the numbers are increasing due to demographic aging. More and more people, including younger people, suffer from neurodegenerative diseases; in Germany, more than 2 million people have dementia or Parkinson's. According to the German Association for Alzheimer's Patients, in 2020, 9,450 people died from Alzheimer's, recording the highest figure. The increase in hospitalizations and deaths with Alzheimer's diagnosis is highly dependent on the aging population in Germany. People aged 65 and above increased by ~33% between and reached 18.3 million in 2020. Therefore, the aging population results in growing neurological disorders, which is expected to boost the market growth in the coming years.

Europe Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)

Europe Deep Brain Simulation Market Segmentation

The Europe deep brain simulation market is segmented into product, application, end user, and country.

Based on product, the Europe deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the Europe deep brain simulation market.

Based on application, the Europe deep brain simulation market is segmented into Parkinson's disease, tremor, dystonia, epilepsy, Alzheimer's disease, and others. In 2022, the Parkinson's disease segment registered the largest share in the Europe deep brain simulation market.

Based on end user, the Europe deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the Europe deep brain simulation market.

Based on country, the Europe deep brain simulation market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. In 2022, Germany segment registered the largest share in the Europe deep brain simulation market.

Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corp, Medtronic Plc, and Newronika SpA are some of the leading companies operating in the Europe deep brain simulation market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe deep brain simulation market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe deep brain simulation market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the deep brain simulation market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Europe Deep Brain Stimulation Market, by Country (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Deep Brain Simulation Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis
  • 4.3 Comparison Analysis
    • 4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
    • 4.3.2 Lesioning Procedures in Neurological Disorders
    • 4.3.3 Europe Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country

5. Europe Deep Brain Simulation Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Rising Prevalence of Neurological Disorders
    • 5.1.2 Increasing Demand for Minimally Invasive Surgery
  • 5.2 Market Restraints
    • 5.2.1 Side Effects Associated with Deep Brain Stimulation
  • 5.3 Market Opportunities
    • 5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
  • 5.4 Future Trends
    • 5.4.1 Growing Research and Development Activities
  • 5.5 Impact Analysis

6. Deep Brain Simulation Market - Europe Market Analysis

  • 6.1 Europe Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030

7. Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Europe Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Single Channel Deep Brain Stimulator
    • 7.3.1 Overview
    • 7.3.2 Single Channel Deep Brain Stimulator: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Dual Channel Deep Brain Stimulator
    • 7.4.1 Overview
    • 7.4.2 Dual Channel Deep Brain Stimulator: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Software and Accessories
    • 7.5.1 Overview
    • 7.5.2 Software and Accessories: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Europe Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Parkinson's Disease
    • 8.3.1 Overview
    • 8.3.2 Parkinson's Disease: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Tremor
    • 8.4.1 Overview
    • 8.4.2 Tremor: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Alzheimer's Disease
    • 8.5.1 Overview
    • 8.5.2 Alzheimer's Disease: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Dystonia
    • 8.6.1 Overview
    • 8.6.2 Dystonia: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Epilepsy
    • 8.7.1 Overview
    • 8.7.2 Epilepsy: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Europe Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Neurology Clinics
    • 9.4.1 Overview
    • 9.4.2 Neurology Clinics: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Ambulatory Surgical Centers
    • 9.5.1 Overview
    • 9.5.2 Ambulatory Surgical Centers: Europe Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Deep Brain Simulation Market - Country Analysis

  • 10.1 Overview
      • 10.1.1.1 Europe Deep Brain Simulation Market by Country
      • 10.1.1.2 Germany
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Germany Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 Germany Deep Brain Simulation Market, by Product
        • 10.1.1.2.4 Germany Deep Brain Simulation Market, by Application
        • 10.1.1.2.5 Germany Deep Brain Simulation Market, by End User
      • 10.1.1.3 UK
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 UK Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 UK Deep Brain Simulation Market, by Product
        • 10.1.1.3.4 UK Deep Brain Simulation Market, by Application
        • 10.1.1.3.5 UK Deep Brain Simulation Market, by End User
      • 10.1.1.4 France
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 France Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 France Deep Brain Simulation Market, by Product
        • 10.1.1.4.4 France Deep Brain Simulation Market, by Application
        • 10.1.1.4.5 France Deep Brain Simulation Market, by End User
      • 10.1.1.5 Italy
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Italy Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.3 Italy Deep Brain Simulation Market, by Product
        • 10.1.1.5.4 Italy Deep Brain Simulation Market, by Application
        • 10.1.1.5.5 Italy Deep Brain Simulation Market, by End User
      • 10.1.1.6 Spain
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Spain Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.3 Spain Deep Brain Simulation Market, by Product
        • 10.1.1.6.4 Spain Deep Brain Simulation Market, by Application
        • 10.1.1.6.5 Spain Deep Brain Simulation Market, by End User
      • 10.1.1.7 Rest of Europe
        • 10.1.1.7.1 Overview
        • 10.1.1.7.2 Rest of Europe Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.7.3 Rest of Europe Deep Brain Simulation Market, by Product
        • 10.1.1.7.4 Rest of Europe Deep Brain Simulation Market, by Application
        • 10.1.1.7.5 Rest of Europe Deep Brain Simulation Market, by End User

11. Pre & Post Covid-19 Impact

  • 11.1 Pre & Post Covid-19 Impact

12. Europe Deep Brain Simulation Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Deep Brain Stimulation Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Europe Deep Brain Simulation Market, Key Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Aleva Neurotherapeutics SA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Medtronic Plc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Boston Scientific Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Newronika SpA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms